Cardiol Therapeutics

+$0.33 (+7.25%) Today
-$0.02 (-0.41%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRDL and other ETFs, options, and stocks.

About CRDL

Cardiol Therapeutics Inc. is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus.

CEO
David G. Elsley
Employees
14
Headquarters
Oakville, Ontario
Founded
2017

CRDL Key Statistics

Market Cap
208.75M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
763.29K
High Today
$4.96
Low Today
$4.40
Open Price
$4.55
Volume
2.29M
52 Week High
$4.96
52 Week Low
$1.82
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure